Robert C. Grant

22.8k total citations · 2 hit papers
90 papers, 3.7k citations indexed

About

Robert C. Grant is a scholar working on Oncology, Cancer Research and Surgery. According to data from OpenAlex, Robert C. Grant has authored 90 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Oncology, 28 papers in Cancer Research and 14 papers in Surgery. Recurrent topics in Robert C. Grant's work include Pancreatic and Hepatic Oncology Research (30 papers), Cancer Genomics and Diagnostics (24 papers) and Genetic factors in colorectal cancer (10 papers). Robert C. Grant is often cited by papers focused on Pancreatic and Hepatic Oncology Research (30 papers), Cancer Genomics and Diagnostics (24 papers) and Genetic factors in colorectal cancer (10 papers). Robert C. Grant collaborates with scholars based in Canada, United States and Australia. Robert C. Grant's co-authors include Simon C. Ling, Aideen M. Moore, Ivan Diamond, Brian M. Feldman, Paul W. Wales, Paul B. Pencharz, Robert D. Wells, J E Larson, C R Cantor and Steven Gallinger and has published in prestigious journals such as Nature, Journal of the American Chemical Society and Journal of Clinical Oncology.

In The Last Decade

Robert C. Grant

82 papers receiving 3.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Defining consensus: A systematic review recommends methodologic criteria for reporting of Delphi studies

2014 1.8k citations Ivan Diamond, Robert C. Grant et al. Journal of Clinical Epidemiology profile →
Physicochemical studies on polydeoxyribonucleotides containing defined repeating nucleotide sequences

1970 517 citations Robert C. Grant et al. profile →

Peers

Countries citing papers authored by Robert C. Grant

Since Specialization

Citations

This map shows the geographic impact of Robert C. Grant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert C. Grant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert C. Grant more than expected).

Fields of papers citing papers by Robert C. Grant

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert C. Grant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert C. Grant. The network helps show where Robert C. Grant may publish in the future.

Co-authorship network of co-authors of Robert C. Grant

This figure shows the co-authorship network connecting the top 25 collaborators of Robert C. Grant. A scholar is included among the top collaborators of Robert C. Grant based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert C. Grant. Robert C. Grant is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Prioritizing the Timely Detection and Diagnosis of Early-Age Onset Cancer to Enable Optimal Disease Management and Outcomes 2025 ·Current Oncology ·Michael J. Raphael, (unknown), Darren R. Brenner, Christine Brezden‐Masley, Ronald L. Burkes, Robert C. Grant, (unknown), (unknown), Monika Slovinec D’Angelo, (unknown)	0
2	Density of T-cell Subsets in Colorectal Cancer in Relation to Disease-Specific Survival 2025 ·Cancer Epidemiology Biomarkers & Prevention ·Claire E. Thomas, Yasutoshi Takashima, Daniel D. Buchanan, Evertine Wesselink, Conghui Qu, Li Hsu, Andressa Dias Costa, Steven Gallinger, Robert C. Grant, Jeroen R. Huyghe, Sushma Thomas, (unknown), (unknown), (unknown), Tomotaka Ugai, Ulrike Peters, Shuji Ogino, Jonathan A. Nowak, Amanda I. Phipps	1
3	Novel Systemic Anticancer Treatments and Health Services Use at the End of Life Among Adults With Cancer 2025 ·Journal of Clinical Oncology ·Javaid Iqbal, Rahim Moineddin, Kieran L. Quinn, Christopher M. Booth, Craig C. Earle, Stéphanie Lheureux, Robert C. Grant, Jenny Lau, Lisa W. Le, Peter Tanuseputro, James Downar, Gary Rodin, Hsien Seow, (unknown), Robert Fowler, Breffni Hannon, Monika K. Krzyzanowska, Camilla Zimmermann	1
4	Functional variants in the cystic fibrosis transmembrane conductance regulator (CFTR) gene are associated with increased risk of colorectal cancer 2025 ·Human Molecular Genetics ·Anna E. Prizment, (unknown), Conghui Qu, (unknown), Shuo Wang, Wen‐Yi Huang, Annika Lindblom, Rachel Pearlman, Bethany Van Guelpen, Alicja Wolk, Daniel D. Buchanan, Robert C. Grant, Stephanie L. Schmit, Elizabeth A. Platz, Corinne E. Joshu, David Couper, Annette Peters, Timothy K. Starr, Patrícia Scott, Nathan Pankratz	1
5	763P Re-VOLVE: Phase II trial in women with ovarian cancer progressing post-PARP-inhibitor with treatment adapted to real-time assessment of evolving genomic resistance 2024 ·Annals of Oncology ·(unknown), (unknown), Neesha C. Dhani, Wang Li, Robert C. Grant, Vikas Garg, Lee Js, (unknown), (unknown), Sandeep Arora, (unknown), (unknown), (unknown), Valerie Bowering, Bernard Lam, (unknown), (unknown), Thomas A. M. Pugh, (unknown)	1
6	Early results of the PASS-01 trial: Pancreatic adenocarcinoma signature stratification for treatment-01. 2024 ·Journal of Clinical Oncology ·Jennifer J. Knox, Elizabeth M. Jaffee, Grainne M. O’Kane, Daniel A. King, Dan Laheru, Kenneth H. Yu, Kimberly Perez, Amber N. Habowski, Robert C. Grant, Sandra E. Fischer, Andrew J. Aguirre, Raymond Woo-Jun Jang, Craig Devoe, Eileen M. O’Reilly, Anna Dodd, Brian M. Wolpin, Xiang Y. Ye, Faiyaz Notta, Steven Gallinger, David A. Tuveson	6
7	Real-World Safety of Niraparib for Maintenance Treatment of Ovarian Cancer in Canada 2024 ·Current Oncology ·(unknown), (unknown), Reka Pataky, (unknown), Maud Marques, Karen Gambaro, (unknown), Katharina Förster, (unknown), David Stock, Louis de Léséleuc, Winson Y. Cheung, Stuart Peacock, (unknown), Scott Gavura, Mina Tadrous, Robert C. Grant, Kelvin Chan	1
8	Vascular Resection for Pancreas Cancer – 10-year Experience from a Single High Volume-center 2024 ·Annals of Surgery ·(unknown), (unknown), (unknown), (unknown), (unknown), Sean P. Cleary, Laura A. Dawson, Elena Elimova, Robert C. Grant, Ali Hosni, Raymond Jang, Jennifer J. Knox, Aruz Mesci, Malcolm Moore, Carol‐Anne Moulton, Trevor Reichman, Chaya Shwaartz, Erica S. Tsang, Ian D. McGilvray, Steven Gallinger	1
9	Association between somatic microsatellite instability, hypermutation status, and specific T cell subsets in colorectal cancer tumors 2024 ·Frontiers in Immunology ·Claire E. Thomas, Yasutoshi Takashima, Evertine Wesselink, (unknown), Robert S. Steinfelder, Daniel D. Buchanan, Conghui Qu, Li Hsu, Andressa Dias Costa, Steven Gallinger, Robert C. Grant, Jeroen R. Huyghe, Sushma Thomas, Shuji Ogino, Amanda I. Phipps, Jonathan A. Nowak, Ulrike Peters	2
10	Comparative Outcome Analysis of Lenvatinib Versus Sorafenib for Recurrence of Hepatocellular Carcinoma After Liver Transplantation 2024 ·Transplantation ·(unknown), (unknown), Luckshi Rajendran, Zhihao Li, (unknown), (unknown), Woo Jin Choi, (unknown), Arndt Vogel, Robert C. Grant, Nazia Selzner, Elmar Jaeckel, (unknown), Jennifer J. Knox, Eric X. Chen, (unknown), Grainne M. O’Kane	4
11	Machine Learning to Allocate Palliative Care Consultations During Cancer Treatment 2024 ·Journal of Clinical Oncology ·(unknown), (unknown), (unknown), (unknown), Ning Liu, Nathan Taback, Steven Gallinger, Breffni Hannon, Monika K. Krzyzanowska, Marzyeh Ghassemi, Kelvin Chan, Robert C. Grant	7
12	Causal debiasing for unknown bias in histopathology—A colon cancer use case 2024 ·PLoS ONE ·Ramón Correa, Rish K. Pai, (unknown), Daniel D. Buchanan, Mark A. Jenkins, Amanda I. Phipps, Polly A. Newcomb, Steven Gallinger, Robert C. Grant, Loı̈c Le Marchand, Imon Banerjee	0
13	288P Recent advances in systemic therapy for advanced biliary tract cancer: A systematic review and meta-analysis 2024 ·Annals of Oncology ·(unknown), Daniel Aliseda, Owen Jones, Luckshi Rajendran, (unknown), Robert C. Grant, Grainne M. O’Kane, (unknown), (unknown), (unknown)	2
14	hENT1 as a Predictive Biomarker in PDAC—Response 2023 ·Clinical Cancer Research ·(unknown), Gun Ho Jang, Robert C. Grant, Faiyaz Notta, Barbara T. Grünwald, Steven Gallinger, Jennifer J. Knox, Grainne M. O’Kane	0
15	Causal relationships between risk of venous thromboembolism and 18 cancers: a bidirectional Mendelian randomization analysis 2023 ·International Journal of Epidemiology ·(unknown), Philip Haycock, Hermann Brenner, Jane C. Figueiredo, Tessel E. Galesloot, Robert C. Grant, Mattias Johansson, Daniela Mariosa, James McKay, Rish K. Pai, Andrew J. Pellatt, N. Jewel Samadder, Jianxin Shi, Florian Thibord, David‐Alexandre Trégouët, Catherine Voegele, (unknown), Andrew Mumford, Ryan Langdon	1
16	Circulating Oncometabolite 2-hydroxyglutarate as a Potential Biomarker for Isocitrate Dehydrogenase (IDH1/2) Mutant Cholangiocarcinoma 2023 ·Molecular Cancer Therapeutics ·(unknown), Grainne M. O’Kane, Warren Mason, (unknown), Pavlina Spiliopoulou, Aaron R. Hansen, Robert C. Grant, Jennifer J. Knox, Tracy Stockley, Gelareh Zadeh, Eric X. Chen	6
17	Development of diagnostic and prognostic molecular biomarkers in hepatocellular carcinoma using machine learning: A systematic review 2022 ·Amanpreet Brar, (unknown), Cristina Baciu, Divya Sharma, Wei Xu, Ani Orchanian‐Cheff, Bo Wang, Jüri Reimand, Robert C. Grant, Mamatha Bhat	5
18	Microsatellite instability/mismatch repair deficiency in pancreatic cancers: the same or different? 2021 ·Gut ·Claudio Luchini, Robert C. Grant, Aldo Scarpa, Steven Gallinger	12
19	Defining consensus: A systematic review recommends methodologic criteria for reporting of Delphi studies breakdown → 2014 ·Journal of Clinical Epidemiology ·Ivan Diamond, Robert C. Grant, Brian M. Feldman, Paul B. Pencharz, Simon C. Ling, Aideen M. Moore, Paul W. Wales	1824
20	CHH volume 40 issue 3 Cover and Front matter 1971 ·Church History ·Robert C. Grant, (unknown), (unknown), (unknown), Robert T. Handy, (unknown), (unknown), Joseph N. Moody, James D. Nichols, Ray C. Petry, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact